Empagliflozin in Treatment of Peripheral Diabetic Neuropathy
NCT05977465
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Diabetic Neuropathy Peripheral
Interventions
DRUG:
Empagliflozin 25 MG
Sponsor
Tanta University